Abcede, Maria T.
HRN: 06-36-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
MUPIROCIN 2%, 15G (TUBE)
01/11/2025
01/17/2025
TOPICAL
Apply On Affected Areas
Bid
Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes